Pancreatic Cancer Research

ResearcherJiangsu Province HospitalNo recent work listed

Wei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9566-8764; OpenAlex author ID A5100705141. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper

Papers 2

  1. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer. Co-author DOI 10.2174/1568009614666140331231658↗
  2. PP2A inhibitors induce apoptosis in pancreatic cancer cell line PANC-1 through persistent phosphorylation of IKKα and sustained activation of the NF-κB pathway. Co-author DOI 10.1016/j.canlet.2011.02.009↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qingyong Ma · 1 shared paper, 2014 · strength 0.04
  2. Liang Han · 1 shared paper, 2014 · strength 0.04
  3. Jiangbo Liu · 1 shared paper, 2014 · strength 0.04
  4. Erxi Wu · 1 shared paper, 2014 · strength 0.04
  5. Wanxing Duan · 1 shared paper, 2014 · strength 0.04
  6. Katie M. Reindl · 1 shared paper, 2014 · strength 0.04
  7. Qinhong Xu · 1 shared paper, 2014 · strength 0.04
  8. Zekuan Xu · 1 shared paper, 2011 · strength 0.02
  9. Jingjing Zhang · 1 shared paper, 2011 · strength 0.02
  10. Zheng Chen · 1 shared paper, 2011 · strength 0.02
  11. Yi Miao · 1 shared paper, 2011 · strength 0.02
  12. Xiao Han · 1 shared paper, 2011 · strength 0.02
  13. Min Tao · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.